Literature DB >> 17366036

Serum myeloperoxidase in cystic fibrosis patients receiving systemic antibiotics.

Stephan A Kohlhoff1, Elke Köhler, Veronika Sollich.   

Abstract

Serial serum myeloperoxidase was determined in 27 cystic fibrosis patients with chronic endobronchial Pseudomonas aeruginosa infection over the course of 1 y. The effect of repeated courses of antibiotic therapy on mean serum myeloperoxidase levels was significant (p = 0.034). Serial serum myeloperoxidase may help to guide therapy for pulmonary exacerbations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366036     DOI: 10.1080/00365540600951259

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis.

Authors:  Ruchi Yadav; Dae-Goon Yoo; J Michelle Kahlenberg; S Louis Bridges; Oluwadamilola Oni; Hanwen Huang; Arlene Stecenko; Balázs Rada
Journal:  J Cyst Fibros       Date:  2019-01-10       Impact factor: 5.482

2.  Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.

Authors:  Vihas T Vasu; Sharon J de Cruz; Jessica S Houghton; Keri A Hayakawa; Brian M Morrissey; Carroll E Cross; Jason P Eiserich
Journal:  Free Radic Res       Date:  2010-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.